clinical trial · NCT06696443
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
Vertex Pharmaceuticals Incorporated·phase3·active not recruiting·n = 455
Diabetic Peripheral Neuropathic PainSuzetrigine
brief summary
The purpose of this study is to evaluate the long-term safety and tolerability of SUZ and long-term effectiveness of SUZ in treating pain associated with DPN.
started
Dec 18, 2024
primary completion
Jan 25, 2027
completion
Jan 25, 2027
last updated
Jan 29, 2026
official title
A Phase 3, Open-label Study Evaluating the Long-term Safety and Effectiveness of Suzetrigine in Subjects With Pain Associated With Diabetic Peripheral Neuropathy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol